Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$212.3M
+18.7% from 2023
Prescriptions
4,801
$44,230.19 per claim
Patients
662
434 prescribers
Total spending, 2024
$212.3M
$320,769.11 per patient
Medicare prescription drug plans paid $212.3M for Krystexxa in 2024, for 4,801 prescriptions and refills to 662 patients (up 18.7% from 2023). The average cost per claim was $44,230.19.
California had the highest Medicare cost for Krystexxa in 2024: $35.8M for 701 claims, followed by Texas ($31.3M).
Elvin R Garcia, rheumatology in McAllen, TX, had the highest Medicare cost for Krystexxa in 2024: 230 claims costing $13.7M.
Krystexxa is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Horizon/Amgen.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Elvin R Garcia McAllen, TX | Rheumatology | 230 | 32 | $13.7M |
| Sunil H Patel Apple Valley, CA | Nephrology | 99 | 14 | $5.4M |
| Victor G Carabello Los Angeles, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 299 | 2,906 | 496 | $123.0M |
| 2023 | 372 | 3,892 | 603 | $178.8M |
| 2024 | 434 | 4,801 | 662 | $212.3M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 78 |
| 15 |
| $4.4M |
| Christopher A Gisler Pittsburgh, PA | Nephrology | 63 | 11 | $3.4M |
| Shree R Mulay Dyersburg, TN | Nephrology | 87 | Under 11 | $2.5M |
| Payam Shakouri Poughkeepsie, NY | Nephrology | 46 | 17 | $2.5M |
| James M Hunt Thomasville, GA | Rheumatology | 71 | Under 11 | $2.5M |
| Naiara Alvarez Harlingen, TX | Rheumatology | 44 | Under 11 | $2.4M |
| Sandra B Reed Taylorsville, NC | Nurse Practitioner | 70 | Under 11 | $2.4M |
| Nizar Eskandar Hinesville, GA | Nephrology | 60 | Under 11 | $2.3M |
| Christopher J Mesa Miami, FL | Rheumatology | 43 | Under 11 | $2.1M |
| Sreesh G Iyengar San Bernardino, CA | Nephrology | 34 | Under 11 | $2.0M |
| Asim R Singh Erie, PA | Nephrology | 33 | Under 11 | $1.9M |
| Jordan L Tran Winchester, VA | Family Practice | 32 | Under 11 | $1.8M |
| Bob Wodecki Statesville, NC | Rheumatology | 31 | Under 11 | $1.7M |
| Sushma Reddycherla Fayetteville, GA | Nephrology | 57 | Under 11 | $1.6M |
| Peter P Hennis Casa Grande, AZ | Nurse Practitioner | 25 | Under 11 | $1.4M |
| Janki Trivedi Sun City, CA | Rheumatology | 24 | Under 11 | $1.4M |
| Alexander M Swan Avenel, NJ | Internal Medicine | 25 | Under 11 | $1.4M |
| Todd D Shenkenberg Harlingen, TX | Medical Oncology | 24 | Under 11 | $1.4M |
| John S Kang Bronx, NY | Nephrology | 26 | Under 11 | $1.4M |
| Fabio Oliveros Sebring, FL | Nephrology | 26 | Under 11 | $1.4M |
| Elizabeth Bui Tyler, TX | Rheumatology | 25 | Under 11 | $1.4M |
| Thet N Zaw Douglas, GA | Nephrology | 43 | Under 11 | $1.3M |
| Katelyn P Pike Montgomery, AL | Nurse Practitioner | 21 | Under 11 | $1.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Horizon/Amgen AMGN | 4,801 | $212.3M |